[1] Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes[J]. J Allergy Clin Immunol,2012,130(3):607-612.
[2] Cottin V. Eosinophilic lung diseases[J]. Clin Chest Med,2016,37(3):535-556.
[3] Malde B, Greenberger PA. Allergic bronchopulmonary aspergillosis.[J]. J Allergy Clin Immunol,2003,110(5):685-692.
[4] Agarwal R, Aggarwal AN, Gupta D, et al. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma:systematic review and meta-analysis[J]. Int J Tuberc Lung Dis,2009,13(8):936-944.
[5] Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis:systematic review and meta-analysis[J]. Clin Exp Allergy,2015,45(12):1765-1778.
[6] Agarwal K, Gaur SN, Chowdhary A. The role of fungal sensitisation in clinical presentation in patients with chronic obstructive pulmonary disease[J]. Mycoses,2015,58(9):531.
[7] Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis. Model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease[J]. Chest,1987,91(6 Suppl):165S-171S.
[8] Lilly LM, Scopel M, Nelson MP, et al. Eosinophil deficiency compromises lung defense against Aspergillus fumigatus[J]. Infect Immun,2014,82(3):1315-1325.
[9] Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis:review of literature and proposal of new diagnostic and classification criteria[J]. Clin Exp Allergy,2013,43(8):850-873.
[10] Agarwal R, Maskey D, Aggarwal A N, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis:a latent class analysis[J]. PLoS One,2013,8(4):e61105.
[11] Greenberger PA. Allergic bronchopulmonary aspergillosis[J]. Allergy & Asthma Proceedings, 2012, 33:S61-S63.
[12] Knutsen AP, Bush RK, Demain JG, et al. Fungi and allergic lower respiratory tract diseases[J]. J Allergy Clin Immunol, 2012,129:280-291.
[13] Chakrabarti A, Denning DW, Ferguson BJ, et al. Fungal rhinosinusitis:a categorization and definitional schema addressing current controversies[J]. Laryngoscope,2009,119(9):1809.
[14] Uri N, Ronen O, Marshak T, et al. Allergic fungal sinusitis and eosinophilic mucin rhinosinusitis:diagnostic criteria[J]. J Laryngol Otol,2013,127(9):867.
[15] Schubert MS. Allergic fungal sinusitis[J]. Otolaryngol Clin North Am,2004,37(2):301-326.
[16] 陈福权. 变态反应与慢性鼻-鼻窦炎[J]. 临床耳鼻咽喉头颈外科杂志,2017,31(1):18-22.
[17] Kuhn FA, Swain RJ. Allergic fungal sinusitis:diagnosis and treatment[J]. Curr Opin Otolaryngol Head Neck Surg,2003,11(1):1-5.
[18] Niedoszytko M, Chemińska M, Jassem E, et al. Association between sensitization to Pullularia sp and severity of asthma[J].Ann Allergy Asthma Immunol,2007,98(2):153.
[19] Hedayati MT, Pasqualotto AC, Warn PA, et al. Aspergillus flavus:human pathogen, allergen and mycotoxin producer[J]. Microbiology,2007,153(Pt 6):1677.
[20] 李琳,周新. 真菌致敏与严重支气管哮喘[J]. 国际呼吸杂志,2011,31(5):369-372.
[21] Yoon J, Ponikau JU, Lawrence CB, et al. Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b[J]. J Immunol,2008,181(4):2907-2915.
[22] 王林林,时国朝. 真菌引起支气管哮喘发展和加重的免疫学机制[J]. 国际呼吸杂志,2011,5(20):1557-1560.
[23] Denning DW, O'Driscoll BR, Hogaboam CM, et al. The link between fungi and severe asthma:a summary of the evidence[J]. Eur Respir J,2006,27(3):615-626.
[24] Lópezmedrano F, Silva J T, Fernándezruiz M, et al. Risk factors associated with early invasive pulmonary aspergillosis in kidney transplant recipients:results from a multinational matched case-control study.[J]. Am J Transplant, 2016, 16(7):2148-2157.
[25] 王业,文富强,Wangye,等. 真菌与临床喘息性疾病[J]. 国际呼吸杂志,2013,7(3):135-139.
[26] Agarwal K, Gaur SN, Chowdhary A. The role of fungal sensitisation in clinical presentation in patients with chronic obstructive pulmonary disease[J]. Mycoses,2015,58(9):531-535.
[27] Bafadhel M, Mckenna S, Agbetile J, et al. Aspergillus fumigatus during stable state and exacerbations of COPD[J]. Eur Respir J,2014,43(1):64-71.
[28] Liu XF, Sun YC, Jin JM, et al. Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease:report of 3 cases[J]. Zhonghua Jie He He Hu Xi Za Zhi,2013,36(10):741-745.
[29] Agarwal R, Srinivas R, Jindal SK. Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease[J]. Mycoses,2008,51(1):83-85.
[30] Agarwal R, Hazarika B, Gupta D, et al. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease:COPD as a risk factor for ABPA[J]? Med Mycol,2010,48(7):988-994.
[31] Mir E, Shah A. Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease[J]. Prim Care Respir J,2012,21(1):111-114.
[32] 吴吉芹,朱利平. 球孢子菌病的流行病学、临床表现及诊治进展[J]. 微生物与感染,2017,12(1):44-49.
[33] Wang XL, Wang S, An CL. Mini-review of published reports on coccidioidomycosis in China[J]. Mycopathologia,2015,180(5-6):299-303.
[34] Charlton V, Ramsdell K, Sehring S. Intrauterine transmission of coccidioidomycosis[J]. Pediatr Infect Dis J,1999,18(6):561-563.
[35] Gaidici A, Saubolle MA. Transmission of coccidioidomycosis to a human via a cat bite[J]. J Clin Microbiol,2009,47(2):505-506.
[36] Nguyen C, Barker BM, Hoover S, et al. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis[J]. Clin Microbiol Rev,2013,26(3):505-525.
[37] Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia[J]. Emerg Infect Dis,2006,12(6):958-962.
[38] Ampel NM. Coccidioidomycosis in persons infected with HIV type 1[J]. Clin Infect Dis,2005,41(8):1174-1178.
[39] Stevens DA. Coccidioidomycosis.[J]. N Engl J Med,1995,332(16):1077-1082.
[40] Storage TR, Segal J, Brown J. Peritoneal coccidioidomycosis:a rare case report and review of the literature[J]. J Gastrointestin Liver Dis,2015,24(4):527-530.
[41] Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia[J]. Clin Infect Dis,1994,18(4):627-629.
[42] Swartz J, Stoller J. Acute eosinophilic pneumonia complicating Coccidioides immitis pneumonia:a case report and literature review.[J]. Respiration,2009,77(1):102-106.
[43] Kassis C, Zaidi S, Kuberski T, et al. Role of Coccidioides antigen testing in the cerebrospinal fluid for the diagnosis of coccidioidal meningitis[J]. Clin Infect Dis,2015,61(10):1521-1526.
[44] Marques SA. Paracoccidioidomycosis.[J]. Clinics in Dermatology,2012,30(6):610.
[45] Mendes RP, Cavalcante RS, Marques SA, et al. Paracoccidioidomycosis:current perspectives from Brazil[J]. Open Microbiol J,2017,11(1):224-282.
[46] Dos SW, Da SB, Passos ED, et al.[J]. Cad Saude Publica,2003,19(1):245-253.
[47] Queiroz-Telles F, Escuissato DL. Pulmonary paracoccidioidomycosis[J]. Semin Respir Crit Care Med,2011,32(6):764-774.
[48] Moreto TC, Marques ME, de Oliveira ML, et al. Accuracy of routine diagnostic tests used in paracoccidioidomycosis patients at a university hospital[J]. Trans R Soc Trop Med Hyg,2011,105(8):473-478.
[49] Braga FG, Ruas LP, Pereira RM, et al. Functional and phenotypic evaluation of eosinophils from patients with the acute form of paracoccidioidomycosis[J]. PLoS Negl Trop Dis,2017,11(5):e0005601.